Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Transactions of the American Clinical and Climatological Association|October 5, 2022
DRUGGING "UNDRUGGABLE" DISEASE-CAUSING PROTEINS: FOCUS ON SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 3David J Tweardy
Transactions of the American Clinical and Climatological Association|June 6, 2008
Enhancing or eliminating signals for cell survival to treat diseaseDavid J Tweardy, Naijie Jing
Anti-Cancer Drugs|June 3, 2005
Targeting Stat3 in cancer therapyNaijie Jing, David J Tweardy
The Journal of Infection|September 28, 2011
Lethal human neutropenic entercolitis caused by Clostridium chauvoei in the United States: tip of the iceberg?Jill E Weatherhead, David J Tweardy
Translational Research : the Journal of Laboratory and Clinical Medicine|November 26, 2009
"Personalizing" academic medicine: opportunities and challenges in implementing genomic profilingDavid J Tweardy, John W Belmont
Drug Discovery Today. Technologies|July 2, 2014
Targeting transcription factors in cancer: Challenges and evolving strategiesMichele S Redell, David J Tweardy
Current Pharmaceutical Design|August 17, 2005
Targeting transcription factors for cancer therapyMichele S Redell, David J Tweardy
Archives of Orthopaedic and Trauma Surgery|May 9, 2002
Requirements for NF-kappaB activation in hemorrhagic shockChristian Hierholzer, Timothy R Billiar, David J Tweardy
Leukemia & Lymphoma|February 13, 2004
Cross-talk between retinoic acid and STAT3 signaling pathways in acute promyelocytic leukemiaShuo Dong, Sai-Juan Chen, David J Tweardy
Pageof 11